Sutro Biopharma Inc (STRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 81,834 | 235,095 | 62,472 | 47,254 | 96,779 |
| Marketable Securities | 273,317 | 156,547 | 214,022 | 287,110 | 227,469 |
| Receivables | 16,627 | 9,999 | 9,873 | 7,122 | 11,241 |
| TOTAL | $381,254 | $411,985 | $304,063 | $353,153 | $346,553 |
| Non-Current Assets | |||||
| PPE Net | 22,344 | 23,636 | 24,029 | 24,621 | 24,281 |
| Other Non-Current Assets | 28,136 | 29,278 | 29,924 | 29,170 | 29,866 |
| TOTAL | $50,480 | $52,914 | $53,953 | $53,791 | $54,147 |
| Total Assets | $431,734 | $464,899 | $358,016 | $406,944 | $400,700 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 7,137 | 10,197 | 13,242 | 12,500 | 12,500 |
| Accounts payable and accrued liabilities | 5,525 | 3,856 | 5,058 | 4,797 | 12,443 |
| Accrued Expenses | 30,787 | 29,102 | 18,749 | 27,906 | 10,380 |
| Other current liabilities | N/A | N/A | N/A | N/A | 4,414 |
| TOTAL | $73,606 | $67,125 | $59,486 | $66,547 | $58,288 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 0 | 0 | 3,771 | 6,783 |
| Deferred Revenues | 23,983 | 18,036 | 17,186 | 16,759 | 15,920 |
| Other Non-Current Liabilities | 167,627 | 163,179 | 28,071 | 29,693 | 31,171 |
| TOTAL | $245,781 | $243,059 | $113,117 | $123,349 | $112,686 |
| Total Liabilities | $319,387 | $310,184 | $172,603 | $189,896 | $170,974 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,095 | 6,053 | 6,042 | 6,016 | 5,748 |
| Common Shares | 61 | 60 | 60 | 58 | 55 |
| Retained earnings | -590,473 | -541,189 | -502,665 | -452,615 | -418,021 |
| Other shareholders' equity | 7 | 16 | -107 | -618 | -1,336 |
| TOTAL | $112,347 | $154,715 | $185,413 | $217,048 | $229,726 |
| Total Liabilities And Equity | $431,734 | $464,899 | $358,016 | $406,944 | $400,700 |